H. Wilkes

发表

Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa

P. Kaleebu, D. Pillay, C. Gale, 2006, AIDS.

A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals.

T. Meade, C. Kelleher, F. Green, 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

in postmenopausal women therapy controlled trial of hormone replacement after menopause (WISDOM): a randomised international study of long duration oestrogen Main morbidities recorded in the women's

T. Meade, A. Maclennan, S. Meredith, 2007 .

Extra-Cranial Bleeding and Other Symptoms due to Low Dose Aspirin and Low Intensity Oral Anticoagulation

P. Roderick, P. Brennan, T. Meade, 1992, Thrombosis and Haemostasis.

SMOKING AND PLASMA FIBRINOGEN

T. Meade, H. Wilkes, C. Kelleher, 1988, The Lancet.

Hormone replacement therapy and cardiovascular disease: the case for a randomized controlled trial.

T. Meade, T. Meade, M. Vickers, 1995, Ciba Foundation symposium.

Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework.

T. Meade, H. Wilkes, 1991, BMJ.

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

P. Easterbrook, H. Namata, A. Siika, 2018, The Lancet. Infectious diseases.

Possibilities of DNA Analysis for the Detection of Predisposition to Thrombotic Disease

S. Humphries, A. Hamsten, P. Brennan, 1992, Annals of the New York Academy of Sciences.

Haemostatic changes that constitute the hypercoagulable state

K. Bauer, R. Rosenberg, G. Miller, 1991, The Lancet.

Arterial disease risk factors and angiographic evidence of atheroma of the carotid artery.

T. Meade, M. Harrison, A. Schneidau, 1989, Stroke.

Variation in the Promoter Region of the β Fibrinogen Gene Is Associated with Plasma Fibrinogen Levels in Smokers and Non-Smokers

S. Humphries, P. Brennan, T. Meade, 1991, Thrombosis and Haemostasis.

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

P. Easterbrook, T. Peto, N. French, 2017, The lancet. HIV.

Randomized controlled trial of low dose warfarin in the primary prevention of ischaemic heart disease in men at high risk: design and pilot study.

P. Brennan, T. Meade, Y. Stirling, 1988, European heart journal.

Gemfibrozil Reduces Plasma Prothrombin Fragment F1+2 Concentration, a Marker of Coagulability, in Patients with Coronary Heart Disease

K. Bauer, R. Rosenberg, G. Miller, 1992, Thrombosis and Haemostasis.

Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality.

W. H. Wilkinson, G. Miller, T. Meade, 1986, Atherosclerosis.

Fat consumption and factor VII coagulant activity in middle-aged men. An association between a dietary and thrombogenic coronary risk factor.

J. Cruickshank, G. Miller, R. Thompson, 1989, Atherosclerosis.

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

J. Seeley, C. Giaquinto, O. Kobusingye, 2021, BMC Infectious Diseases.

Effects of Oral Contraceptives and Obesity on Protein C Antigen

P. Mannucci, T. Meade, Y. Stirling, 1985, Thrombosis and Haemostasis.

Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial

J. Seeley, A. Walker, N. Klein, 2018 .

Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men.

J. Cruickshank, G. Miller, H. Wilkes, 1989, Atherosclerosis.

Pregnancy rates and outcomes among women on triple-drug antiretroviral therapy (ART) in the DART trial.

C. Gilks, D. Gibb, C. Kityo, 2009 .

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Ana C. Matos, C. Königs, C. Giaquinto, 2022, The lancet. HIV.

Hormone replacement therapy in general practice.

T. Meade, H. Wilkes, 1991, BMJ.

The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.

P. Roderick, T. Meade, H. Wilkes, 1993, British journal of clinical pharmacology.

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.

A. Breckenridge, P. Kaleebu, D. Pillay, 2010, Lancet.

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

A. Breckenridge, P. Kaleebu, D. Pillay, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Ana C. Matos, C. Königs, J. Seeley, 2022, The lancet. HIV.

Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial

J. Seeley, K. Maitland, A. Shali, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pregnancy and pregnancy outcome among women in the DART trial.

C. Gilks, D. Gibb, C. Kityo, 2007 .

Dietary and other characteristics relevant for coronary heart disease in men of Indian, West Indian and European descent in London.

W. H. Wilkinson, T. Meade, T. Sanders, 1988, Atherosclerosis.

Genetic factors determining thrombosis and fibrinolysis.

S. Humphries, A. Hamsten, B. Wiman, 1992, Annals of epidemiology.

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women

Anthony Dowell, Sally Rose, T. Meade, 2007, BMJ : British Medical Journal.

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial

P. Easterbrook, N. French, H. Namata, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

RABBIT (TO REPLACE HUMAN) BRAIN MATERIAL IN ANTICOAGULANT CONTROL

T. Meade, Y. Stirling, H. Wilkes, 1987, The Lancet.

Decision-making about hormone replacement therapy by women in England and Scotland

S. Meredith, C. Knott, J. Hepworth, 2004, Climacteric : the journal of the International Menopause Society.

Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial

J. Seeley, A. Shali, A. Walker, 2018, The lancet. HIV.

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

A. Breckenridge, P. Kaleebu, D. Pillay, 2010, The Lancet.

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women

T. Meade, A. Maclennan, J. Darbyshire, 2007, BMJ : British Medical Journal.

Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial

J. Seeley, N. Klein, F. Fitzgerald, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.